4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid

C23H28N4O4 — CID 67842204

IUPAC4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid
SMILESCCCCN1C(=O)N(C)C(=O)/C1=C\c1cnc(CCC)n1Cc1ccc(C(=O)O)cc1
InChIInChI=1S/C23H28N4O4/c1-4-6-12-26-19(21(28)25(3)23(26)31)13-18-14-24-20(7-5-2)27(18)15-16-8-10-17(11-9-16)22(29)30/h8-11,13-14H,4-7,12,15H2,1-3H3,(H,29,30)/b19-13+
InChIKeyDRMHSGFFCWROBY-CPNJWEJPSA-N
MW424.50 g/mol
LogP3.62
Rot. Bonds9

About 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid

4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid (PubChem CID 67842204) has the molecular formula C23H28N4O4 and a molecular weight of 424.50 g/mol. Its IUPAC name is 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid.

Molecular Properties

Compound Name4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid
PubChem CID67842204
Molecular FormulaC23H28N4O4
Molecular Weight424.50 g/mol
Exact Mass424.21
IUPAC Name4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid
SMILESCCCCN1C(=O)N(C)C(=O)/C1=C\c1cnc(CCC)n1Cc1ccc(C(=O)O)cc1
InChIInChI=1S/C23H28N4O4/c1-4-6-12-26-19(21(28)25(3)23(26)31)13-18-14-24-20(7-5-2)27(18)15-16-8-10-17(11-9-16)22(29)30/h8-11,13-14H,4-7,12,15H2,1-3H3,(H,29,30)/b19-13+
InChIKeyDRMHSGFFCWROBY-CPNJWEJPSA-N
XLogP3.62
TPSA95.74 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500424.50
LogP ≤ 53.62
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid?
The IUPAC name of 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid (CID 67842204) is 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid.
What is the SMILES notation for 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid?
The canonical SMILES for 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid is CCCCN1C(=O)N(C)C(=O)/C1=C\c1cnc(CCC)n1Cc1ccc(C(=O)O)cc1.
What is the InChIKey of 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid?
The InChIKey is DRMHSGFFCWROBY-CPNJWEJPSA-N. The full InChI is InChI=1S/C23H28N4O4/c1-4-6-12-26-19(21(28)25(3)23(26)31)13-18-14-24-20(7-5-2)27(18)15-16-8-10-17(11-9-16)22(29)30/h8-11,13-14H,4-7,12,15H2,1-3H3,(H,29,30)/b19-13+.
What are the key properties of 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid?
4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid has a molecular weight of 424.50 g/mol, XLogP of 3.62, 9 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[5-[(E)-(3-butyl-1-methyl-2,5-dioxoimidazolidin-4-ylidene)methyl]-2-propylimidazol-1-yl]methyl]benzoic acid is sourced from PubChem (CID 67842204), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).